Biotech Values

[genisi]

There was an oral presentation at ASCO 2009: Inhibition of ALK mutated neuroblastomas by the selective inhibitor PF-02341066. Abs.:

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=35242